Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
Date:
29 Aug,2022
5 Month, Acquiring Tangshan Bohai Pharmaceutical Co., Ltd.
Previous page
2009
2004
Next page
Related Recommendations
2024/05/17
Tech Month | The Inaugural "Tech Month" Event Launch Conference of Wanbangde Pharmaceutical Group Successfully Held
Warmest congratulations to Wanbangde Pharmaceutical Group on receiving the U.S. FDA’s “Rare Pediatric Disease” designation for Huperzine A!
2024/05/06
Unbeatable in every match, victorious in every game—Wanbangde Pharmaceutical Group Employees' Table Tennis Tournament Concludes in Spectacular Fashion!